Literature DB >> 19915481

Chronic kidney disease in hypertension under specialist care: the I-DEMAND study.

Giovanna Leoncini1, Francesca Viazzi, Enrico Agabiti Rosei, Ettore Ambrosioni, Francesco V Costa, Gastone Leonetti, Achille C Pessina, Bruno Trimarco, Massimo Volpe, Giacomo Deferrari, Roberto Pontremoli.   

Abstract

OBJECTIVE AND METHODS: Italy Developing Education and awareness on MicroAlbuminuria in patients with hyperteNsive Disease is an observational, cross-sectional, multicenter study aimed at determining prevalence and correlates of chronic kidney disease (CKD) among Italian hypertensive patients attending out-patient referral clinics. CKD was defined as glomerular filtration rate (GFR) less than 60 ml/min per 1.73 m (Modification of Diet in Renal Disease equation) or urine albumin to creatinine ratio of at least 2.5 mg/mmol in men and of at least 3.5 mg/mmol in women or both.
RESULTS: Among 3534 study patients (mean age 61 years, 54% male patients, 37% diabetic patients), the prevalence of microalbuminuria, reduced GFR, and CKD was 27, 26, and 42%, respectively. Only 11% of patients had concomitant microalbuminuria and reduced GFR. Sex, smoking, systolic blood pressure, glucose, and GFR were the independent predictors of albumin to creatinine ratio, whereas sex, age, history of cardiovascular diseases, uric acid, abdominal obesity, and albumin to creatinine ratio were more closely related to GFR. The presence of CKD was associated with older age, smoking, higher systolic and pulse pressure levels, impaired fasting glucose, hyperuricemia, and previous cardiovascular disease. Furthermore, CKD was not only associated with a greater use of renin-angiotensin system-inhibiting, lipid-lowering and antiplatelet drugs but also with inadequate blood pressure control.
CONCLUSION: Renal abnormalities are found in a significant number of hypertensive patients. CKD occurs more often in older patients and in those with associated metabolic risk factors or clinical conditions. These results suggest the need to improve awareness of the role of renal damage as a component of global risk and to develop appropriate therapeutic strategies to reduce morbidity and mortality in this specific subgroup of patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19915481     DOI: 10.1097/HJH.0b013e328332038c

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  22 in total

1.  Increased urine semaphorin-3A is associated with renal damage in hypertensive patients with chronic kidney disease: a nested case-control study.

Authors:  Francesca Viazzi; Ganesan Ramesh; Calpurnia Jayakumar; Giovanna Leoncini; Debora Garneri; Roberto Pontremoli
Journal:  J Nephrol       Date:  2014-04-23       Impact factor: 3.902

2.  Looking at the kidney to predict global outcome in the elderly.

Authors:  Francesca Viazzi; Elena Ratto; Giovanna Leoncini; Roberto Pontremoli
Journal:  Intern Emerg Med       Date:  2014-06-18       Impact factor: 3.397

Review 3.  An analysis of the management of cardiovascular risk factors in routine clinical practice in Italy: an overview of the main findings of the EFFECTUS study.

Authors:  Giuliano Tocci; Andrea Ferrucci; Pietro Guida; Angelo Avogaro; Marco Comaschi; Alberto Corsini; Claudio Cortese; Carlo B Giorda; Enzo Manzato; Gerardo Medea; Gian F Mureddu; Gabriele Riccardi; Giulio Titta; Giuseppe Ventriglia; Giovanni B Zito; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2011-03-01

Review 4.  Chronic kidney disease in the hypertensive patient: an overview of the I-DEMAND study.

Authors:  Giovanna Leoncini; Francesca Viazzi; Enrico Agabiti Rosei; Ettore Ambrosioni; Francesco V Costa; Gastone Leonetti; Achille C Pessina; Bruno Trimarco; Massimo Volpe; Giacomo Deferrari; Roberto Pontremoli
Journal:  High Blood Press Cardiovasc Prev       Date:  2011-03-01

5.  Hyperphosphatemia is associated with overt proteinuria in non-diabetic patients with late-stage chronic kidney disease: a cross-sectional study.

Authors:  Yit-Sheung Yap; Wen-Che Chi; Cheng-Hao Lin; Yi-Wen Wu; Yi-Chun Liu
Journal:  Int Urol Nephrol       Date:  2012-03-31       Impact factor: 2.370

6.  Safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic kidney disease patients not on hemodialysis.

Authors:  Gurunanthan Palani; Zehra Husain; Rafael Cabrera Salinas; Vanji Karthikeyan; Aarthee S Karthikeyan; Karthik Ananthasubramaniam
Journal:  J Nucl Cardiol       Date:  2011-05-04       Impact factor: 5.952

7.  Attitudes and preferences for the clinical management of patients with hypertension and hypertension with chronic obstructive pulmonary disease in Italy: main results of a survey questionnaire.

Authors:  Giuliano Tocci; Arrigo F Cicero; Massimo Salvetti; Jasmine Passerini; Maria Beatrice Musumeci; Andrea Ferrucci; Claudio Borghi; Massimo Volpe
Journal:  Intern Emerg Med       Date:  2015-05-19       Impact factor: 3.397

8.  Factors related to nephrotic-range proteinuria in late-stage chronic kidney disease patients with diabetes mellitus.

Authors:  Yit-Sheung Yap; Hung-Yi Chuang; Wen-Che Chi; Cheng-Hao Lin; Yi-Wen Wu; Pai-Chun Chang; Yi-Chun Liu
Journal:  Int Urol Nephrol       Date:  2013-01-26       Impact factor: 2.370

9.  Microalbuminuria in subjects with hypertension attending specialist blood pressure clinics.

Authors:  A A Alharf; S Cleland; J Webster; G T McInnes; S Padmanabhan
Journal:  J Hum Hypertens       Date:  2015-12-17       Impact factor: 3.012

Review 10.  Effects of dual inhibition of renin-angiotensin-aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefits.

Authors:  Giuliano Tocci; Barbara Citoni; Vivianne Presta; Giovanna Leoncini; Francesca Viazzi; Barbara Bonino; Massimo Volpe; Roberto Pontremoli
Journal:  Intern Emerg Med       Date:  2019-12-21       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.